- Bone tumors can be benign, intermediate, or malignant lesions. They are classified based on factors like aggressiveness, metastatic potential, and histological grade.
- Imaging tools like x-rays, CT, MRI, and radionuclide scanning are used to evaluate bone tumors and detect any metastases. Biopsy is the gold standard for diagnosis.
- Treatment depends on the type and stage of the bone tumor. It may involve surgery, radiation therapy, chemotherapy, or a combination. The goal is to make the patient disease-free while preserving function and limb salvage when possible.
This is a short presentation on avascular necrosis of femoral head. This presentation gives brief description of causes of AVN, investigations and modes of treatment options available.
AVN TREATMENT IN HYDERABAD
Core decompression for AVN
Stem cell treatment for AVN
Surgery for AVN
Avascular necrosis treatment options
Hip replacement in hyderabad
Hip specialist in hyderabad
Hip surgery in hyderabad
Total hip replacement in hyderabad
cemented hip replacement
uncemented hip replacement in hyderabad
ceramic hip replacement
delta motion hip
ceramic on ceramic hip replacement
metal on poly hip replacement
affordable hip replacement in hyderabad
Metastasis is the MC malignancy of bone.
Breast cancer is the MC primary site.
Others include:
Prostate ,Lung ,Kidney and thyroid
Nature of metastasis
Osteolytic:
Destructive
Most mets (breast**, lung, kidney etc)
Osteoblastic:
Reactive new bone formation
Carcinoma prostate**, breast Ca.
This is a short presentation on avascular necrosis of femoral head. This presentation gives brief description of causes of AVN, investigations and modes of treatment options available.
AVN TREATMENT IN HYDERABAD
Core decompression for AVN
Stem cell treatment for AVN
Surgery for AVN
Avascular necrosis treatment options
Hip replacement in hyderabad
Hip specialist in hyderabad
Hip surgery in hyderabad
Total hip replacement in hyderabad
cemented hip replacement
uncemented hip replacement in hyderabad
ceramic hip replacement
delta motion hip
ceramic on ceramic hip replacement
metal on poly hip replacement
affordable hip replacement in hyderabad
Metastasis is the MC malignancy of bone.
Breast cancer is the MC primary site.
Others include:
Prostate ,Lung ,Kidney and thyroid
Nature of metastasis
Osteolytic:
Destructive
Most mets (breast**, lung, kidney etc)
Osteoblastic:
Reactive new bone formation
Carcinoma prostate**, breast Ca.
Presentation on bone tumors for undergraduate 2nd year MBBS medical students. The information for this presentation has been taken from texbook of Robbins & Cotran Pathologic Basis of Disease 8th ed.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Epidemiology
• Bone and soft tissue sarcoma – derived from mesenchymal origin
• Bone sarcoma – 0.2%
• Male > Female
• Age – male >85 years , female- 50-60 years
9. General approach
• History- patient information, Pain , Mass
• Examination
• Investigation
• Imaging ( X rays , CT , MRI , Radionuclide scanning)
• Systemic evaluation ( in case of secondaries)
• PSA, Bence- Jones protein, Serum Calcium, ALP
• ESR , CRP
• Biopsy – gold standard
10.
11.
12. Clinical Presentation
• Asymptomatic
• Pain
• Swelling/mass
All superficial soft tissue lesions measuring >5cm and all deep seated lesions
should be considered a sarcoma until proven otherwise
• Pathological fractures
• Systemic findings
23. Lesions of the Spine
Older than 40 Years
• Metastases
Vertebral body, pelvis
Proximal femur, proximal humerus
skull
• Multiple myeloma
• Hemangioma
• Chordoma (in sacrum)
Younger than 30 Years
Vertebral body
• Histiocytosis
• Hemangioma
Posterior elements
• Osteoid osteoma
• Osteoblastoma
• Aneurysmal bone cyst
25. Sclerotic metastasis
• Prostatic Ca
• Breast Ca
• Transitional Cell Ca
• Carcinoid
• Mucinous Adeno Ca
Lytic bone metastasis
• Lung Ca
• Renal Cell Ca
• Thyroid Ca
• Adrenal gland Ca
• Uterine Ca
• Melanoma
26. • Computed tomography
• Shows accurately intraosseous and extraosseous extension
• Great for cortical bone evaluation
• Helps in staging
• MRI
• Defines local extent of lesion , tissue characterization
• Useful in assessing soft tissue tumor and cartilaginous tumor
• Radionuclide scanning
• 99mTcMDP – non specific reactive changes – reveal site of small
tumor (osteoid osteoma)
• Detecting skip lesions , evidence of metastatic disease
27. Enneking staging system
• Based on:
• Tumor grade
• Metastasis
• Confinement in compartment
• A compartment, for the purposes of this system, is defined as an
enclosed tissue space, such as a bone, a joint space or a muscle group
confined by its fascial envelope
28. Enneking staging system
Malignant
Stage Grade Site Metastasis
IA Low Grade Intra-
compartmental
No metastasis
IB Low Grade Extra-
compartmental
No metastasis
IIA High Grade Intra-
compartmental
No metastasis
IIB High Grade Extra-
compartmental
No metastasis
III Any Any Metastases
Benign
1. Latent—low biologic activity; well
marginated; often incidental findings (i.e.,
nonossifying fibroma)
2. Active—symptomatic; limited bone
destruction; may present with pathologic
fracture (i.e., aneurysmal bone cyst)
3. Aggressive—aggressive; bone
destruction/soft-tissue extension(i.e., giant
cell tumor)
33. Biopsy-Principles
• Referred to the institution where definitive treatment will take place.
• Should be done after clinical, lab and radiographic examinations
• Planned placement of biopsy incision
• biopsy track should be considered contaminated with tumor cells
• biopsy track needs to be excised en bloc with the tumor
• The surgeon performing the biopsy should be familiar with incisions
for limb salvage surgery and standard and nonstandard amputation
flaps
34. Biopsy- Principles
• If a tourniquet is used, the limb elevated before inflation but should
not be exsanguinated by compression to prevent “squeezing” the
tumor’s cells into the systemic circulation
• Transverse incisions should be avoided
• The deep incision should go through single muscle compartment
• Avoid major neurovascular structure
• Soft tissue extension of bone lesion should be sampled
35. Biopsy- Principles
• hole in the bone should be round
or oval
• Frozen section should be sent
intraoperatively to ensure that
diagnostic tissue has been
obtained
• meticulous hemostasis ensured
before closure
• Drain should exit in line with the
incision
• Wound should be closed tightly in
layers
36. Biopsy- Principles
• Sample should be sent for microbiology as well as histology
• The pathologist reporting biopsy must have an appropriate level of
experience
• If risk of fracture following biopsy, bone must be splinted
40. Management
• Primary Goal with primary malignancy- make patient disease free
• Goal of treatment of patient with metastatic carcinoma to bone:
Minimize pain
Preserve function
Optimal treatment of tumor :
Surgery
Radiation therapy
Chemotherapy
41. Radiation therapy
• Blue cell tumor
• Multiple myeloma
• Lymphoma
• Ewings sarcoma
• Secondaries (Except – RCC)
• Reduce local recurrence of malignant soft tissue tumor
Bone sarcoma – 0.2% of all new cancers diagnosed UK , Appleys
Age-specific incidence rates (ASIR) for soft-tissue sarcomas and primary sarcomas of bone (a) Softtissue sarcomas in the UK 1996–2010; (b) primary bone sarcomas in the UK for the same period (National Cancer Intelligence Network (NICN) data).
bone sarcomas demonstrate a bimodal distribution in both males and females, with peaks of incidence seen in both teenage/adolescent years and the elderly
Benign – doesn’t invade and spread surrounding tissue, non destructive , surgical resection – curative
Osteoblastoma – infiltrative and locally destructive growth pattern – en bloc resection – curative
Higher grade tumor have > 25% chance of local recurrence and distant spread
Low grade lesion< 25 % chance of local recurrence and mets
IF tumors are analyzed, there is preferential sites of origin within each bone. A particular tumor of given cell type usually arises in the field where homologous normal cells are most active . Eg GCT
Age , Sex (GCT: F>M), Race , Hereditary – Multiple hereditary exostosis AD
Katanoda, K., Shibata, A., Matsuda, T., Hori, M., Nakata, K., Narita, Y., … Nishimoto, H. (2017). Childhood, adolescent and young adult cancer incidence in Japan in 2009–2011. Japanese Journal of Clinical Oncology, 47(8), 762–771
CMF = Chondromyxoid fibroma
SBC = Simple Bone Cyst
EG = Eosinophilic Granuloma
FD = Fibrous dysplasia
HPT = Hyperparathyroidism with Brown tumor
Pain – night pain referred pain
Pathological fractures – 5-12% osteosarcoma , 21% in chondrosarcoma
s/c # of femur in children, avulsion # of L/T in adults – bone tumors
Very little trabecular bone in the diaphysis to provide an interface to allow the lesion to be seen
Simple Bone Cyst /unicameral bone cyst
If diaphyseal lesion is on radiograph cortex is involved , large medullary cavity diaphyseal lesion may be invisible d/t little trabecular bone in diaphysis to provide interface to allow lesion to be seen
Osteoid osteoma
99mTcMDP – methyl diphosphonate
aid in treatment decision making, provide some determination of prognosis, and allow meaningful comparisons of treatment methods.
A compartment, for the purposes of this system, is defined as an enclosed tissue space, such as a bone, a joint space or a muscle group confined by its fascial envelope
Low grade : well differentiated , few mitoses and exibit moderate cytological atypia , risk of mets<25%
High grade : high cell to matrix ratio
A: well defined anatomical compartment (cortex, joint capsule , fascial septa)
Tumor node metastasis staging- applied to primary sarcomas of bone
AJCC System – based on prognostic variables
Stage I- low grade , II high grade
Skip metastasis – discontinuous lesion within the same bone
Since the patient with non pulmonary metastasis from osteosarcoma and ewings sarcoma have worse prognosis than with pulmonary mets
Raw area is covered with bone wax or methylmethacrylate cement to reduce bleeding , contamination from cut bone edge
because they are extremely difficult or impossible to excise with the specimen
single muscle compartment rather than contaminating an intermuscular plane
round or oval to minimize stress concentration and prevent a subsequent fracture
The hole should be plugged with methacrylate to limit hematoma formation.
meticulous hemostasis ensured before closure, because a hematoma would be contaminated with tumor cells
Drain should exit in line with the incision so that the drain track also can be easily excised en bloc with the tumor
Complications : infection , bleeding/hematoma , pathological fracture , tumor contamination and seeding
FNAC : 90% accurate in dx malignancy
Core needle biopsy : accuracy 84-98%
Excisional biopsy : <3cm , sc mass , unlikely malignant – osteoid osteoma , osteochondroma
Painful lesion in proximal fibula and distal ulna
Large opacification on medial thigh separate from femur
Osteopetrosis – Marble bone disease- confused with sclerotic metastates from breasr and prostate ca , Pagets disease
Osteopoikilosis- AD sclerosing bone dysplasia formation of multiple bone island
Melorheostosis- mesenchymal dysplasia – widening and sclerosing of cortices in sclerotomal distribution
Adjuvant chemotherapy refers to chemotherapy administered postoperatively to treat presumed micrometastases.
Neoadjuvant chemotherapy refers to chemotherapy administered
before surgical resection of the primary tumor